Literature DB >> 1416881

Chitin biosynthesis in Candida albicans grown in vitro and in vivo and its inhibition by nikkomycin Z.

T Chapman1, O Kinsman, J Houston.   

Abstract

An N-acetyl-D-[14C]glucosamine radiolabel incorporation assay has been used to monitor chitin biosynthesis in whole cells of Candida albicans both in vitro and in vivo in two different mouse infection models, one using the peritoneal cavity as a chamber in which to add and retrieve cells and the other using infected kidneys. Specific labeling of chitin in alkali-insoluble material was confirmed by chitinase digestion, analysis of acid hydrolysates, and the use of nikkomycin Z as a probe. Nikkomycin Z was shown to strongly inhibit chitin biosynthesis in C. albicans grown in vitro and in vivo in both models. This demonstrates that nikkomycin Z-susceptible chitin synthase activity is present in C. albicans when the fungus is in its pathogenic state in vivo. The limited use of nikkomycin as a therapeutic agent is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416881      PMCID: PMC192208          DOI: 10.1128/AAC.36.9.1909

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

Review 1.  Cell wall of Candida albicans: its functions and its impact on the host.

Authors:  A Cassone
Journal:  Curr Top Med Mycol       Date:  1989

2.  Cell wall composition of the mycelial and blastospore forms of Candida albicans.

Authors:  F W Chattaway; M R Holmes; A J Barlow
Journal:  J Gen Microbiol       Date:  1968-05

3.  A characterization of pH-regulated dimorphism in Candida albicans.

Authors:  J Buffo; M A Herman; D R Soll
Journal:  Mycopathologia       Date:  1984-03-15       Impact factor: 2.574

4.  Isolation of a chitin synthase gene (CHS1) from Candida albicans by expression in Saccharomyces cerevisiae.

Authors:  J Au-Young; P W Robbins
Journal:  Mol Microbiol       Date:  1990-02       Impact factor: 3.501

5.  Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis.

Authors:  R F Hector; B L Zimmer; D Pappagianis
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

6.  An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans.

Authors:  K L Lee; H R Buckley; C C Campbell
Journal:  Sabouraudia       Date:  1975-07

7.  Synergistic action of nikkomycins X and Z with papulacandin B on whole cells and regenerating protoplasts of Candida albicans.

Authors:  R F Hector; P C Braun
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

8.  Chitin synthesis in Candida albicans: comparison of yeast and hyphal forms.

Authors:  P C Braun; R A Calderone
Journal:  J Bacteriol       Date:  1978-03       Impact factor: 3.490

9.  Regulation of chitin synthesis during germ-tube formation in Candida albicans.

Authors:  Y Y Chiew; M G Shepherd; P A Sullivan
Journal:  Arch Microbiol       Date:  1980-03       Impact factor: 2.552

10.  Polyoxin D inhibits growth of zoopathogenic fungi.

Authors:  J M Becker; N L Covert; P Shenbagamurthi; A S Steinfeld; F Naider
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

View more
  10 in total

1.  Novel bifunctional inhibitor of xylanase and aspartic protease: implications for inhibition of fungal growth.

Authors:  C Dash; A Ahmad; D Nath; M Rao
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

Review 2.  Antifungal peptides: novel therapeutic compounds against emerging pathogens.

Authors:  A J De Lucca; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

3.  In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole.

Authors:  R K Li; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

4.  In vitro efficacy of nikkomycin Z against the human isolate of the microsporidian species Encephalitozoon hellem.

Authors:  E Bigliardi; A M Bernuzzi; S Corona; S Gatti; M Scaglia; L Sacchi
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

5.  Attenuated virulence of chitin-deficient mutants of Candida albicans.

Authors:  C E Bulawa; D W Miller; L K Henry; J M Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

6.  Characterizing the role of cell-wall β-1,3-exoglucanase Xog1p in Candida albicans adhesion by the human antimicrobial peptide LL-37.

Authors:  Pei-Wen Tsai; Cheng-Yao Yang; Hao-Teng Chang; Chung-Yu Lan
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

Review 7.  Identification and characterization of enzymes involved in the biosynthesis of pyrimidine nucleoside antibiotics.

Authors:  M McErlean; X Liu; Z Cui; B Gust; S G Van Lanen
Journal:  Nat Prod Rep       Date:  2021-07-21       Impact factor: 15.111

8.  Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the fks Mutants.

Authors:  Yuk-Yam Cheung; Mamie Hui
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

9.  Characterization of a fungal competition factor: Production of a conidial cell-wall associated antifungal peptide.

Authors:  Sheng Tong; Maolian Li; Nemat O Keyhani; Yu Liu; Min Yuan; Dongmei Lin; Dan Jin; Xianbi Li; Yan Pei; Yanhua Fan
Journal:  PLoS Pathog       Date:  2020-04-23       Impact factor: 6.823

10.  Genome-wide transcriptomic analysis of the response of Botrytis cinerea to wuyiencin.

Authors:  Liming Shi; Binghua Liu; Qiuhe Wei; Beibei Ge; Kecheng Zhang
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.